Histologically Remarkable Eosinophilic Esophagitis Responsive to Dupilumab in a Gastrostomy Tube–Dependent Pediatric Patient on Amino Acid Formula
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Castro, KennyArostegui, Dalia
Schwarz, Steven
Gandhi, Sonia
Peshimam, Juveria
Rabinowitz, Simon
Pittman, Meredith
Wallach, Thomas
Journal title
JPGN ReportsDate Published
2022-11Publication Volume
3Publication Issue
4Publication Begin page
e250
Metadata
Show full item recordAbstract
Eosinophilic esophagitis (EoE), an eosinophil predominant, TH2-mediated condition increasing in prevalence in pediatric and adult populations, is typically treated with dietary manipulations to avoid triggering antigens. However, identifying specific dietary causes remains a persistent challenge, and restrictive diets are burdensome. Total dietary modification using amino acid–based formula does not always produce symptomatic or histologic resolution, suggesting that exposure to ingested aeroallergens drives their disease. EoE patients demonstrate symptomatic exacerbation from July to September correlating with higher grass and ragweed pollen counts. We present a 7-year-old tracheostomy- and gastrostomy-dependent girl who was found on surveillance endoscopy to have profound eosinophilic infiltration throughout the esophagus with inflammatory changes including basal cell hyperplasia on histology. She responded partially to topical corticosteroid therapy with fluticasone and had complete resolution of esophageal eosinophilic infiltrate with subcutaneous dupilumab.Citation
Castro, Kenny MD*; Arostegui, Dalia MD*; Schwarz, Steven MD*; Gandhi, Sonia MD†; Peshimam, Juveria MBBS†; Rabinowitz, Simon MD*; Pittman, Meredith MD‡,§; Wallach, Thomas MD*. Histologically Remarkable Eosinophilic Esophagitis Responsive to Dupilumab in a Gastrostomy Tube–Dependent Pediatric Patient on Amino Acid Formula. JPGN Reports: November 2022 - Volume 3 - Issue 4 - p e250 doi: 10.1097/PG9.0000000000000250DOI
10.1097/pg9.0000000000000250ae974a485f413a2113503eed53cd6c53
10.1097/pg9.0000000000000250
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International